Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Elise Kerdreux"'
Autor:
Caroline Trang-Poisson, Elise Kerdreux, Alexandra Poinas, Lucie Planche, Harry Sokol, Pascale Bemer, Karine Cabanas, Eliane Hivernaud, Laetitia Biron, Laurent Flet, Emmanuel Montassier, Ghislaine Le Garcasson, Anne Chiffoleau, Alexandra Jobert, Didier Lepelletier, Jocelyne Caillon, Patrice Le Pape, Berthe-Marie Imbert, Arnaud Bourreille
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-13 (2020)
Abstract Background Almost 15% of patients with ulcerative colitis (UC) will require a proctocolectomy with ileal pouch–anal anastomosis (IPAA) as a result of fulminant colitis, dysplasia, cancer, or medical refractory diseases. Around 50% will exp
Externí odkaz:
https://doaj.org/article/03718ae4861e486b9acd89748790a2ca
Autor:
Nina Dib, Laurent Siproudhis, Mathurin Flamant, Arnaud Bourreille, Pierre-Antoine Gourraud, Elodie Cesbron-Métivier, Elise Kerdreux, Guillaume Bouguen, Alexandra Poinas, C Le Berre, Thomas Goronflot, Marie Dewitte, Caroline Trang-Poisson
Publikováno v:
Journal of Crohn's and Colitis. 14:S299-S301
Background Inflammatory bowel diseases (IBD) are disabling disorders. The IBD-Disability Index (IBD-DI) was developed for quantifying disability in IBD patients but is difficult to use. The IBD-Disk is a shortened and visual adaptation of the IBD-DI.
Autor:
Alexandra Poinas, Elise Kerdreux, Mathurin Flamant, Laurent Siproudhis, Caroline Trang-Poisson, Elodie Cesbron-Métivier, Nina Dib, C. Le Berre, M. Hanf, Marie Dewitte, Pierre-Antoine Gourraud, Arnaud Bourreille, Thomas Goronflot, Guillaume Bouguen
Publikováno v:
BMC Gastroenterology
BMC Gastroenterology, BioMed Central, 2020, 20 (1), ⟨10.1186/s12876-020-01246-7⟩
BMC Gastroenterology, Vol 20, Iss 1, Pp 1-8 (2020)
BMC Gastroenterology, BioMed Central, 2020, 20 (1), ⟨10.1186/s12876-020-01246-7⟩
BMC Gastroenterology, Vol 20, Iss 1, Pp 1-8 (2020)
Background Inflammatory Bowel Diseases (IBD) affect psychological, family, social and professional dimensions of patients’ life, leading to disability which is essential to quantify as part of Patient-Reported Outcomes (PROs) newly included in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c5c81ab6fa098a7aca621f7ff61dd16
https://hal.univ-angers.fr/hal-03287291
https://hal.univ-angers.fr/hal-03287291
Autor:
Laurent Siproudhis, Guillaume Bouguen, Pierre-Antoine Gourraud, Mathurin Flamant, Arnaud Bourreille, Caroline Trang-Poisson, Thomas Goronflot, Matthieu Hanf, Elodie Cesbron-Métivier, Alexandra Poinas, Elise Kerdreux, Catherine Le Berre, Marie Dewitte, Nina Dib
Publikováno v:
Journal of Crohn's and Colitis
Journal of Crohn's and Colitis, Elsevier-Oxford University Press, 2020, 14 (11), pp.1512-1523. ⟨10.1093/ecco-jcc/jjaa100⟩
Journal of Crohn's and Colitis, 2020, 14 (11), pp.1512-1523. ⟨10.1093/ecco-jcc/jjaa100⟩
Journal of Crohn's and Colitis, Elsevier-Oxford University Press, 2020, 14 (11), pp.1512-1523. ⟨10.1093/ecco-jcc/jjaa100⟩
Journal of Crohn's and Colitis, 2020, 14 (11), pp.1512-1523. ⟨10.1093/ecco-jcc/jjaa100⟩
Background and Aims Inflammatory bowel diseases [IBD] are disabling disorders. The IBD-Disability Index [IBD-DI] was developed for quantifying disability in IBD patients but is difficult to use. The IBD-Disk is a visual adaptation of the IBD-DI. It h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a74ad7045f0bfb5b82f8677b5c00fad5
https://hal.univ-angers.fr/hal-03287277
https://hal.univ-angers.fr/hal-03287277
Autor:
Ghislaine Le Garcasson, Caroline Trang-Poisson, Lucie Planche, Pascale Bémer, Elise Kerdreux, Alexandra Poinas, Harry Sokol, Karine Cabanas, Patrice Le Pape, Alexandra Jobert, Emmanuel Montassier, Jocelyne Caillon, Didier Lepelletier, Laurent Flet, Laetitia Biron, Eliane Hivernaud, Berthe-Marie Imbert, Arnaud Bourreille, Anne Chiffoleau
Publikováno v:
Trials
Trials, BioMed Central, 2020, 21 (1), ⟨10.1186/s13063-020-04330-1⟩
Trials, 2020, 21 (1), ⟨10.1186/s13063-020-04330-1⟩
Trials, Vol 21, Iss 1, Pp 1-13 (2020)
Trials, BioMed Central, 2020, 21 (1), ⟨10.1186/s13063-020-04330-1⟩
Trials, 2020, 21 (1), ⟨10.1186/s13063-020-04330-1⟩
Trials, Vol 21, Iss 1, Pp 1-13 (2020)
Background Almost 15% of patients with ulcerative colitis (UC) will require a proctocolectomy with ileal pouch–anal anastomosis (IPAA) as a result of fulminant colitis, dysplasia, cancer, or medical refractory diseases. Around 50% will experience p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::771f4ed03e72a49abf4b0e4aaf8e6d5b
https://doi.org/10.21203/rs.3.rs-18555/v1
https://doi.org/10.21203/rs.3.rs-18555/v1
Autor:
Chantal Bridonneau, Emmanuel Montassier, Amandine Le Roy, Francine Jotereau, Céline Bossard, Arnaud Bourreille, Justine Mathé, Nadege Marec, Harry Sokol, Guillaume Sarrabayrouse, Frédéric Altare, Emmanuelle Godefroy, Anne Jarry, Joudy Alameddine, Juliette Desfrançois-Noël, Elise Kerdreux
Publikováno v:
Gastroenterology
Gastroenterology, WB Saunders, 2018, 155 (4), pp.1205-1217. ⟨10.1053/j.gastro.2018.06.078⟩
Gastroenterology, 2018, 155 (4), pp.1205-1217. ⟨10.1053/j.gastro.2018.06.078⟩
Gastroenterology, WB Saunders, 2018, 155 (4), pp.1205-1217. ⟨10.1053/j.gastro.2018.06.078⟩
Gastroenterology, 2018, 155 (4), pp.1205-1217. ⟨10.1053/j.gastro.2018.06.078⟩
International audience; BACKGROUND & AIMS:Faecalibacterium prausnitzii, a member of the Clostridium IV group of the Firmicutes phylum that is abundant in the intestinal microbiota, has anti-inflammatory effects. The relative level of F prausnitzii is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::912e2aa5fbafdbfe9c34805e69c582f0
https://www.hal.inserm.fr/inserm-01968888
https://www.hal.inserm.fr/inserm-01968888
Autor:
Emmanuelle, Godefroy, Joudy, Alameddine, Emmanuel, Montassier, Justine, Mathé, Juliette, Desfrançois-Noël, Nadège, Marec, Céline, Bossard, Anne, Jarry, Chantal, Bridonneau, Amandine, Le Roy, Guillaume, Sarrabayrouse, Elise, Kerdreux, Arnaud, Bourreille, Harry, Sokol, Francine, Jotereau, Frédéric, Altare
Publikováno v:
Gastroenterology. 155(4)
Faecalibacterium prausnitzii, a member of the Clostridium IV group of the Firmicutes phylum that is abundant in the intestinal microbiota, has anti-inflammatory effects. The relative level of F prausnitzii is decreased in fecal samples from patients